NSE:STARHEALTH Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, NSE:STARHEALTH stock has a consensus rating of "Buy" and an average price target of ₹589.21. The average 1-year stock price forecast is 2.29% lower than the current stock price, while the lowest is ₹440.00 (-27.03%) and the highest is ₹730.00 (+21.06%).

Price Target: ₹589.21 (-2.29%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹440.00	₹589.21	₹605.00	₹730.00
Change	-27.03%	-2.29%	+0.33%	+21.06%

Analyst Ratings

The average analyst rating for NSE:STARHEALTH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	14	14	14	14	14	14
Buy	2	2	2	2	3	3
Hold	3	3	3	3	3	3
Sell	2	2	2	2	2	2
Strong Sell	1	1	1	1	1	1
Total	22	22	22	22	23	23

Financial Forecast

Revenue This Year

216.10B

from 178.33B

21.18%

from 178.33B

Revenue Next Year

247.71B

from 216.10B

14.63%

from 216.10B

EPS This Year

17.75

from 9.47

87.39%

from 9.47

EPS Next Year

22.72

from 17.75

28.04%

from 17.75

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	106.03B	121.00B	140.25B	161.10B	178.33B	216.10B
Revenue Growth	109.94%	14.12%	15.91%	14.87%	10.69%	21.18%
Net Income	-10.41B	6.19B	8.45B	6.46B	5.57B	11.16B
EPS	-	-	-	-	9.47	17.75
EPS Growth	-	-	-	-	-12.80%	87.39%
Forward PE	205.61	33.39	29.70	22.39	32.14	33.98
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	228.2B
Avg	216.1B
Low	205.2B

Revenue Growth

Revenue Growth	2027	2028	2029
High	28.0%
Avg	21.2%
Low	15.1%

EPS Forecast

EPS	2027	2028	2029
High	27.00
Avg	17.75
Low	12.20

EPS Growth

EPS Growth	2027	2028	2029
High	185.1%
Avg	87.4%
Low	28.9%